SIAP
ABMD

Sterling Investment Advisors (Pennsylvania)’s Abiomed Inc ABMD Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-80
Closed -$26K – 547
2020
Q4 		$26K Hold
80
– – 0.01% 289
2020
Q3 		$22K Sell
80
-70
-47% -$20.2K 0.01% 288
2020
Q2 		$36K Hold
150
– – 0.01% 247
2020
Q1 		$21K Hold
150
– – 0.01% 260
2019
Q4 		$25K Hold
150
– – 0.01% 278
2019
Q3 		$27K Buy
150
+20
+15% +$4.32K 0.01% 266
2019
Q2 		$34K Buy
130
+30
+30% +$7.96K 0.02% 247
2019
Q1 		$29K Buy
100
+70
+233% +$23.3K 0.01% 266
2018
Q4 		$9K Buy
+30
New +$10.4K 0.01% 340

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s ABMD Position: Q1 2021 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 80 shares — an estimated $26K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in ABMD in Q4 2018 and held it in 9 quarters. The position peaked at $36K in Q2 2020. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 80 Abiomed Inc shares in Q1 2021, an estimated $26K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Abiomed Inc in Q4 2018 and held it in 9 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Abiomed Inc position peaked at $36K in Q2 2020.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q1 2021, filed 4 May 2021.